TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Investigator's Global Assessment 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to primary end point
Endpoint domain: Mortality/survival
Primary endpoint: Vertebral heart score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: acute nausea reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spo2/Fio2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hypoproteinemia frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Discontinuation for any reason
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3/4 adverse events prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Deaths owing to adverse events
Endpoint domain: Mortality/survival
Primary endpoint: Fear of relapse
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anterior chamber flare values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural Assessment Scale for Stroke patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke Rehabilitation Movement Assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of the course
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: emotional expression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: group bonding
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Attitude scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Practice scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: plasma concentrations of total, essential, branched‐chain, and non‐proteogenic amino acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thymus size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in serum creatinine from baseline to 48-72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Program discontinuation rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Normalization of LDH values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from COVID-19 symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SARS-CoV-2 negativity by day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Maternal satisfaction on birth process
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bypass time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Apical lesions healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost savings from medication changes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: persistent QFT‐GIT reversion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB occurrence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tract stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Frequency of asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Disability (DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Bloating frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: navicular height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total ischemic and bleeding events
Endpoint domain: Mortality/survival
Primary endpoint: Upper limb performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in ACTACQAQLQFEV1FEV1%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Participants' understanding of study results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Importance of sharing study results
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Willingness to participate in future studies
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: FEV1% and FEV1/FVC%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: acute recurrence rate of COPD
Endpoint domain: Adverse events/effects
Primary endpoint: Pain interference on daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to relapse after ustekinumab withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year cumulative recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Specificity for identification of IEDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for identification of IEDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sit‐n‐Reach measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Goniometric measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ability to kill Brugia malayi microfilariae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tone of posts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progress updates
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Caregivers' depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: chance of external dysuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement in hope
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Performance in the intention retention phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cys-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in haemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients with anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in plasma sST2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in serum hs-Troponin I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in GSES scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: antimicrobial efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: F1 score for NLP vs manual chart review
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for NLP vs manual chart review
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: subsequent vertebral fracture
Endpoint domain: Mortality/survival
Primary endpoint: fat-free mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h ambulatory blood pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Differentiation of endometriosis from healthy women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease staging of endometriosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion against poliovirus types 1 and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody titres against poliovirus types 1 and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion against type 2 poliovirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SNOT-22 reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of agitated patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Coma Scale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: belief in the importance of PA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean rScO2 difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fraction of patients reaching remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: place of death
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety and feasibility of repeated autologous bone marrow-derived cell therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in sedentary behavior (LSB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meeting the weight-loss goal
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overall happiness with life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Desire to change life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Overall satisfaction with life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Roseburia abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal SBA concentrations (lithocolic acid and deoxycholic acid)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SENTIA scores for suicidal behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with an SRI-4 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in distal UE motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC score for any serious mental disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1-Month Follow-up cannabis relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normoglycemia at week 68
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvements in FPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Consumption of morning snacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rucaparib pharmacokinetics (PK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 12-month survival with favorable neurobehavioral outcome
Endpoint domain: Mortality/survival
Primary endpoint: DAS28 (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resolution of zoster associated pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact on patient outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Impact on family outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact on health system outcomes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Bone mineralization of lumbar spine and femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capacity measured in 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of repeat attenders
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Likelihood of receiving safeguarding
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: skeletal and dental changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2peak during 10MTW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shortening of reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long-term outcome of AABs detected when < 15 mm diameter
Endpoint domain: Mortality/survival
Primary endpoint: Time spent to remove DM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incorrect DM stripping
Endpoint domain: Adverse events/effects
Primary endpoint: MDA status maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basic self-disturbance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity of aneurysm detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACT score meeting clinically defined cutoff for poorly controlled asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of ever having symptoms in the past 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of any unplanned clinical utilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of occupational stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MYOD1 methylation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MYF5 mRNA expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MYF6 mRNA expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Ca wt%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in P wt%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caretaker Knowledge Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PSQ‐18 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical success at 12-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in SRC (spike response characteristics)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of SGRQ responders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: isokinetic plantar flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ATRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: re-rupture
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative air-bone gap within 20 dB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximizing acceptance/usability of intervention components
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximizing participation in the trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time difference to perform the TUG test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Processing speed performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: temporomandibular joint pain
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of children consuming a sufficient diversity of foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-hour systolic blood pressure decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of death for cancers at stages 3 or 4
Endpoint domain: Mortality/survival
Primary endpoint: risk of incident cancer that had metastasized
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: risk of incident cancer diagnosed at stage 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Exclusive breastfeeding improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of iron-folic acid supplements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Volume of wound bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum pulling force of removing foam material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of residual foreign body in wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidences of grade > 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory complications at 1 yr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of meaningful rehabilitation applications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Increase in IgA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in Lactobacillus and Bifidobacterium abundances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in oral health conditions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of vomiting episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: vomiting duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pattern comparison processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluid composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life after childbirth
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Emotional exhaustion levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: screening completion proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of participants lost to follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mandibular preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median urinary iodine concentration (MUIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pressure pain threshold in the lower back
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's internalizing problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: children's adjustment problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decrease in adolescent sexual risk behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptoms reported during blood draw
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment for reaction
Endpoint domain: Adverse events/effects
Primary endpoint: BDRI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in TNSS versus placebo for adult/adolescent SAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in TNSS versus placebo for adult/adolescent PAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDA risk estimate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: homeostatic model assessment of insulin resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum high‐sensitive C‐reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: faecal Akkermansia muciniphila
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pre‐TKA KSKS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total citric acid excretion level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total urinary THP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total TCM syndrome score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the self-help intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status